| Financial Year |
March 31 2023 |
| Monetary Funds |
555,856,515.15 |
| Held-for-trading Financial Assets |
155,942,833.37 |
| Notes Receivable |
28,819,085.57 |
| Accounts Receivable |
61,866,943.82 |
| Advances to Suppliers |
380,414.62 |
| Other Receivables |
6,629,852.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
40,844,958.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
17,702,421.13 |
| Other Current Assets |
3,997,552.38 |
| Total Current Assets |
872,989,405.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
26,358,511.58 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,249,839.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,156,877.17 |
| Deferred Income Tax Assets |
14,028,861.70 |
| Other Non-Current Assets |
7,599,253.98 |
| Sub-Total of Non-Current Assets |
102,341,277.67 |
| Total Assets |
975,330,683.14 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
22,037,712.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,407,020.82 |
| Taxes Payable |
1,729,483.46 |
| Interest Payable |
-- |
| Dividend Payable |
137,403.82 |
| Other payables |
25,410,416.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,532,934.81 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
117,918,173.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,378,130.01 |
| Other Non-Current Liabilities |
8,350,480.47 |
| Sub-Total of Non-Current Liabilities |
14,906,180.62 |
| Total Liabilities |
132,824,353.88 |
| Paid-In Capital(Or Share Stock) |
283,142,990.00 |
| Capital Surplus |
442,495,962.02 |
| Surplus Reserve |
37,743,477.10 |
| LESS:Treasury Stock |
22,719,522.81 |
| Undistributed Profits |
114,795,268.10 |
| Minority Stockholder's Interest |
-16,699,279.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
859,205,608.74 |
| Owner's Equity（Stockholder's Equity） |
842,506,329.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
975,330,683.14 |
